Sedation Patient Articles & Analysis
14 news found
Oncomfort, the Belgian inventor of and leader in Digital Sedation - a new method for relieving patients’ pain and anxiety without medication - today announces the completion of a €10 million Series A funding round co-led by two prominent institutional investors: Debiopharm and Crédit Mutuel Innovation. ...
In some cases patients need to be sedated or calmed through the administration of other drugs. General: Administered via intravenous injection or inhalation, general anesthetics do make a patient unconscious. The unique details of each patient determine the use of this procedure. ...
EvoEndo® was founded by clinicians to address the significant need to reduce the use of general anesthesia and sedation during endoscopic procedures in pediatric and adult patients. The use of sedation in endoscopy increases the risk of adverse events, imposes significant pre- and post-procedure burdens on patients and clinic ...
ByEvoEndo
While traditional endoscopy requires patients to undergo general anesthesia or sedation, the EvoEndo System combines sterile, single-use, flexible endoscopes, a portable video controller, and a take-home “comfort kit” containing virtual reality (VR) goggles for patient entertainment and distraction during the procedure to allow for ...
ByEvoEndo
In 2017, Oncomfort created a medical device for Digital Sedation™, a digital therapeutic alternative to pharmacological sedation. More than 80.000 patients have already been treated with Digital Sedation™ in regular practice, demonstrating the feasibility and validity of delivering sedation during ...
EvoEndo’s system combines a sterile, single-use, flexible, ultra-slim gastroscope with virtual reality (VR) patient entertainment to allow the procedure to be performed safely in children and adults without anesthesia or sedation. ...
ByEvoEndo
EvoEndo’s system combines sterile, single-use, flexible endoscopes with VR-based patient distraction to allow the procedure to be performed safely in children and adults without anesthesia or sedation. ...
ByEvoEndo
ncomfort, the leader in Digital Sedation™, a digital therapy to relieve patient anxiety and pain, today announces that it has obtained the ISO 13485:2016 certification by certification company DARE!! ...
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today announced the results of ...
Liberate Medical today announced that it has received Federal Drug Administration (FDA) Emergency Use Authorization for its VentFree™ Respiratory Muscle Stimulator, intended to be used to reduce disuse atrophy of the abdominal wall muscles, which may reduce the number of days adult patients require mechanical ventilation, including those patients with ...
No device or procedure related serious adverse events (SAEs) were reported and all device or procedure related adverse events were mild in severity. In total, 45 patients enrolled in the study, of which 40 patients underwent the study procedure. ...
VentFree is intended to prevent abdominal muscle atrophy and reduce ventilation duration in mechanically ventilated patients. Liberate published the results of its pilot trial of VentFree in July, which found a shorter ventilation duration and ICU length of stay in patients who received VentFree compared with standard of care. ...
“The results from this successful pilot study support our belief that VentFree has the potential to save lives, reduce morbidity and significantly decrease hospital costs for these patients.” About Prolonged Mechanical Ventilation Approximately 40% of patients who need mechanical ventilation need it for more than four days, and the number of these ...
” About Prolonged Mechanical Ventilation Approximately 40% of mechanically ventilated patients require more than four days of ventilator support, and the number of these patients is increasing at 5.5% per year. ...